Procyon Advisors LLC Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Procyon Advisors LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,744 shares of the medical equipment provider's stock after buying an additional 487 shares during the quarter. Procyon Advisors LLC's holdings in Intuitive Surgical were worth $3,520,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the third quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the 4th quarter worth $36,000. Mark Sheptoff Financial Planning LLC purchased a new stake in Intuitive Surgical during the 2nd quarter worth about $37,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical in the 3rd quarter valued at about $38,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on ISRG. Evercore ISI reissued a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird increased their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research report on Thursday, October 17th. Leerink Partners boosted their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. BTIG Research raised their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. Finally, Wells Fargo & Company increased their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the company an "overweight" rating in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $554.17.

Intuitive Surgical Trading Up 1.5 %

Shares of ISRG traded up $8.56 during mid-day trading on Friday, hitting $592.64. The company's stock had a trading volume of 2,630,118 shares, compared to its average volume of 1,158,623. The firm has a 50-day simple moving average of $540.66 and a 200 day simple moving average of $498.77. Intuitive Surgical, Inc. has a 1-year low of $362.14 and a 1-year high of $597.68. The firm has a market capitalization of $211.09 billion, a P/E ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the business's stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares of the company's stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 48,190 shares of company stock worth $25,012,927. 0.80% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.